Anyfusion technology, which means that any medicine or liquid can be precisely injected, is a technology that has been developed with different technologies depending on its function, such as infusion pump and syringe pumps for injecting medicines, PCA for pain suppression, and blood transfusion pumps that were not mechanically transfused due to hemolysis. These devices have used pumps of different technologies depending on their functions so far, but Anyfusion has been confirmed to be a whole in one concept pump capable of all in one pump regardless of the control function and purpose of the cartridge with PID control technology. We decided to promote a platform business that reflects the following conditions and reality, focusing on Anyfusion technology that has unique and unrivaled advantages such as automatic dispensing and automatic drug dispensing and infusion in intensive care units and wards that were not exposed to anticancer drugs.

1. Compared to conventional pumps that are not guaranteed for 2 hours accuracy and persistence, Anyfusion does not need to check and record the injection amount every hour with an accuracy within ±2% of real-time 72 to 96 hours. The only technology that is suitable for building an ideal smart system by only replacing the container and ensuring the reliability of stable injection for more than 72 hours.

2. In addition to being able to provide various functions such as medicine injection, PCA, Blood transfusion pump (BTP), and feeding with one pump, it is an all-in-one function including anti-cancer drugs, TPN, etc.

3. After dispensing with Anyfusion technology on AACPi and ACPi with HIS linkage and scanner function with Anyfusion pump with BAR code generator, scan the bar code attached with patient information, prescription information, dispensing information, and audit information in the packaging container. By scanning the patient information held by the patient, the user (nurse) checks the PC or order point by one by one, and fundamentally solves human errors caused by manual input and manipulation with Anyfusion of the smart system, and injection information (situation, status, alarm, etc.) to real-time central nursing office PC or tablet PC dedicated to hospitals Smart function that minimizes the heavy work of users (nurse) who check and manage injection information one by one.

4. Although when preparing a highly toxic anticancer drug, a robot that extracts drugs from container A and introduces them into container B is not exposed to anticancer drugs when prepared and prepared in a sterile facility and When extracting a drug from a liquid drug container, negative pressure is generated as much as the amount extracted. Even a robot that solved the difficulty of accurately extracting drugs, exposure to anticancer drugs is irresistible when the syringe and needle with an anticancer drug residual amount are separated and discarded. There are a lot of dissatisfaction with waste treatment and the high cost (recently presented 15~1.6 billion won) compared to inefficient dispensing compared to heavy work because there are many various chores in the preparation process before dispensing by Robot. AACPi and ACPi are not exposed to anticancer drugs and do not use a syringe, so there is no waste, and the device automatically prepares all processes by simply setting the kit to the device and absolute competitiveness with reasonable and low price compared.

5. Although CSTD eliminates the occurrence of negative pressure and facilitates drug extraction with the correct amount, When extracting from an anticancer drug container and introducing a dispensing container, CSTD is inevitably exposed to the anticancer drug, and when handling the used syringe and needle, heavy work and high cost treatment costs are incurred due to the same exposure and chores as the robot. , Without CSTD, a pharmacist uses a syringe with no difference from manual dispensing. Excessive work and high wage labor costs are the problem.

6. AACPi and ACPi do not use syringes and needles, so they are not exposed to anticancer drugs at all from preparation to injection. As well as relieving excessive stress from exposure to anticancer drugs, there is no waste disposal, which simplifies work and saves money. One of ACPI with 2-3 people, conducted the preparation of more than 300 cases per day, the amount of dispensing that is incomparable to the robot of preparing 100 cases, and the cost of consumables and items added when using CSTD must be prepared by the pharmacist. Resolving the difficulty in supply and demand for pharmaceutical pharmacists avoiding the pharmaceutical work due to difficulties is the uniqueness of AACPi and ACPi technologies.

7. Need for APIS (Automatic preparation & infusion system) products with automatic preparation and real-time transmission of infusion information linked to HIS for preparation of general wards or intensive care units that have low risk, but solved the difficulty of preparing general drugs in wards and ICUs.

8. HIS linked and real-time transmission of injection information, partial IoT function smart system minimizes medical accidents by reducing human errors

It solves the problems in the preparation of anticancer drugs, and there is no substitute, and AACPi, ACPi, and APIS of the HIS-linked smart system are identified as indispensable products both at domestic and abroad. "Focusing on HIS-linked ACPi, ACPi, and APIS" We are leading the anticancer drug formulation and injection market estimated at over 10 trillion won as of 2020, and With the HIS-linked smart system, our goal is to establish itself as a global leader in the preparation and infusion market of general wards and intensive care units. We have confirmed "Anyfusion platform business" in the field of pharmaceutical preparation and injection focusing on Anyfusion technology, which is a core source technology, as a core project of Meinntech.

We will be a leader in the drug preparation and infusion pump market by changing the market paradigm step by step by introducing AACPi, ACPi, APIS and easily building a smart system solution through strategic R&D and EZ Regular and fusion marketization business policies.

We have Anyfusion technology, which is the core source technology of First Mover, not Fast Follow, so Anyfusion Platform Businness is possible and we want to challenge the global leader with your support.

Thank you.